Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001723643-25-000011·OnKure Therapeutics, Inc.
Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105
Event date: 2025-05-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shay Capital LLC
Shares: 810,214.00 · Class: 6.3%
- Shay Capital Holdings LLC
Shares: 810,214.00 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001723643-25-000011
- Form type
- SCHEDULE 13G
- Filer
- OnKure Therapeutics, Inc.
- CIK
- CIK 1637715
- Filed
- May 29, 2025
- Reporting period
- May 15, 2025
- Description
- Schedule 13G beneficial ownership